Neostigmine Methylsulfate (single dose syringe) 1 mg per mL 5 mg per 5 mL Injectable Hospital/Office Use Only Compounded by: Premier Pharmacy Labs., Inc. 8265 Commercial Way Weeki Wachee, FL 34613, NDC# 69623-234-15
Published December 27, 2017 · Recall initiated: August 10, 2017
Summary
FDA records drug Class II recall D-0129-2018, published December 27, 2017 and initiated August 10, 2017. Recalling firm: Premier Pharmacy Labs Inc; Status: Terminated; Reported quantity: 1610 syringes; Lot: Lot # NEO071317MMDSA BUD: 01/19/2018 Lot # NEO071317MMDSC BUD: 01/19/2018 Lot # NEO071317MMDSF BUD: 01/19/2018. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Stability Date Doesn't Support Expiry: labeling error indicating a beyond use date that exceeds current stability data.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Premier Pharmacy Labs Inc
- Distributor
- Michigan, Maryland, Minnesota, North Carolina, Ohio, Florida
- Lot
- Lot # NEO071317MMDSA BUD: 01/19/2018 Lot # NEO071317MMDSC BUD: 01/19/2018 Lot # NEO071317MMDSF BUD: 01/19/2018
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDADroperidol Injectable Sterile Solution, 0.625mg/mL, 1mL in a 3mL Sterile Single-Use Syringe, Rx only, PremierJuly 3, 2019
- FDANeostigmine Methylsulfate, 5mg/5mL (1mg/mL), 5mL Single Dose Syringe, Rx only, Premier Pharmacy Labs, 8265July 3, 2019
- FDABrilliant Blue Ophthalmic PF INJ, 0.5mg/mL (0.05%), 1 mL SDV, Rx only, Premier Pharmacy Labs, 8265 CommercialJuly 3, 2019
- FDASUCCINYLcholine Chloride, 100mg/5mL (20mg/mL), 5mL Sterile Single-Use Syringe, Rx only, Premier Pharmacy Labs,July 3, 2019
- FDAMaximum Strength Zephrex-D, Pseudoephedrine HCl, 30 mg, Nasal Decongestant. 24 softgel tablets per paperDecember 27, 2017
- FDAAll Sterile Products within expiryDecember 27, 2017
Questions about this recall
Was Neostigmine Methylsulfate (single dose syringe) 1 mg per mL 5 mg per 5 mL Injectable Hospital/Office Use Only Compounded by: Premier Pharmacy Labs., Inc. 8265 Commercial Way Weeki Wachee, FL 34613, NDC# 69623-234-15 recalled?
Yes. FDA published recall D-0129-2018 on December 27, 2017. Reported hazard: Stability Date Doesn't Support Expiry: labeling error indicating a beyond use date that exceeds current stability data.
What should I do if I have this product?
Voluntary: Firm initiated · Letter